🇺🇸 FDA
Pipeline program

FLUDARABINE PHOSPHATE, ALDESLEUKIN, LN-145, FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE

C-145-04

Phase 2 small_molecule active

Quick answer

FLUDARABINE PHOSPHATE, ALDESLEUKIN, LN-145, FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE for Recurrent, metastatic, or persistent Cervical Carcinoma is a Phase 2 program (small_molecule) at Iovance Biotherapeutics B.V. with 1 ClinicalTrials.gov record(s).

Program details

Company
Iovance Biotherapeutics B.V.
Indication
Recurrent, metastatic, or persistent Cervical Carcinoma
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials